tiprankstipranks
Grand Pharmaceutical Group Limited (HK:0512)
:0512
Hong Kong Market
0512
Grand Pharmaceutical Group Limited
RESEARCH TOOLSreports
Want to see HK:0512 full AI Analyst Report?

Grand Pharmaceutical Group Limited (0512) Stock Forecast & Price Target

5 Followers
See the Price Targets and Ratings of:

0512 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Grand
Pharmaceutical Group Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0512 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:0512 In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

0512 Financial Forecast

0512 Earnings Forecast

The previous quarter’s earnings for 0512 were HK$0.02.
The previous quarter’s earnings for 0512 were HK$0.02.

0512 Sales Forecast

The previous quarter’s earnings for 0512 were HK$6.18B.
The previous quarter’s earnings for 0512 were HK$6.18B.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Huatai Securities Analyst forecast on HK:0512
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$12
Buy
128.14%
Upside
Reiterated
03/29/26
Huatai Securities Sticks to Their Buy Rating for Grand Pharmaceutical Group Limited (0512)
Guoyuan Securities (HK) Analyst forecast on HK:0512
Unknown Analyst
Guoyuan Securities (HK)
Not Ranked
Guoyuan Securities (HK)
HK$11.88
Buy
125.86%
Upside
Reiterated
12/15/25
Grand Pharmaceutical Group Limited (0512) Gets a Buy from Guoyuan Securities (HK)
Citic Securities Analyst forecast on HK:0512
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$13
Buy
147.15%
Upside
Reiterated
09/02/25
CICC Analyst forecast on HK:0512
Unknown Analyst
CICC
Not Ranked
CICC
HK$11.7
Buy
122.43%
Upside
Reiterated
08/23/25
TFI Asset Management Analyst forecast on HK:0512
Unknown Analyst
TFI Asset Management
Not Ranked
TFI Asset Management
HK$13.07
Buy
148.48%
Upside
Reiterated
08/13/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Huatai Securities Analyst forecast on HK:0512
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$12
Buy
128.14%
Upside
Reiterated
03/29/26
Huatai Securities Sticks to Their Buy Rating for Grand Pharmaceutical Group Limited (0512)
Guoyuan Securities (HK) Analyst forecast on HK:0512
Unknown Analyst
Guoyuan Securities (HK)
Not Ranked
Guoyuan Securities (HK)
HK$11.88
Buy
125.86%
Upside
Reiterated
12/15/25
Grand Pharmaceutical Group Limited (0512) Gets a Buy from Guoyuan Securities (HK)
Citic Securities Analyst forecast on HK:0512
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$13
Buy
147.15%
Upside
Reiterated
09/02/25
CICC Analyst forecast on HK:0512
Unknown Analyst
CICC
Not Ranked
CICC
HK$11.7
Buy
122.43%
Upside
Reiterated
08/23/25
TFI Asset Management Analyst forecast on HK:0512
Unknown Analyst
TFI Asset Management
Not Ranked
TFI Asset Management
HK$13.07
Buy
148.48%
Upside
Reiterated
08/13/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

0512 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
1
1
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
1
0
0
0
In the current month, 0512 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0512 average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

0512 Stock Forecast FAQ

What is HK:0512’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:0512’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:0512, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Grand Pharmaceutical Group Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is Grand Pharmaceutical Group Limited’s share price target?
      Currently, no data Available
      What do analysts say about Grand Pharmaceutical Group Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Grand Pharmaceutical Group Limited?
      To buy shares of HK:0512, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.